From Euro report ( Botanix Web page) 6th of Apri 2023
Acknowledging these businesses vary in different ways (business model, disease areas, existing licensing agreements, ex-US approvals, and product portfolios), indicatively the market has paid:
7x to 23x (14x average) 2-year forward Revenues;
and15x to 90x (45x average) 2-year forward EBITDA..
happy to use 10x on Revenue...
From Euro report ( Botanix Web page) 6th of Apri...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.0¢ | $1.949M | 5.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 163455 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 33207 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |